Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of a Once Daily Evening Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents

NCT00252278 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.

NCT NCT00252278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00252278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of a Once Daily Evening Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents
Lead sponsor
Rhode Island Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2005
Completion date
Not reported
Enrollment
36
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention-deficit/hyperactivity disorder (adhd), insomnia